Compare EDIT & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDIT | HQI |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | N/A | 75000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.9M | 144.5M |
| IPO Year | 2016 | 2008 |
| Metric | EDIT | HQI |
|---|---|---|
| Price | $2.95 | $11.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $5.30 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.4M | 16.0K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.08% |
| EPS Growth | 37.50 | ★ 73.08 |
| EPS | N/A | ★ 0.45 |
| Revenue | ★ $31,937,000.00 | $30,640,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.46 |
| P/E Ratio | ★ N/A | $25.47 |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.43 | $7.38 |
| 52 Week High | $4.54 | $12.48 |
| Indicator | EDIT | HQI |
|---|---|---|
| Relative Strength Index (RSI) | 49.21 | 51.56 |
| Support Level | $1.95 | $10.09 |
| Resistance Level | $3.17 | $11.61 |
| Average True Range (ATR) | 0.24 | 0.69 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 28.46 | 44.55 |
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.